Mesoblast Shares Fall Despite Record Sales
Mesoblast (ASX: MSB) shares fell around 7% on Tuesday, trading near A$1.98, after the company reported its best-ever quarterly Ryoncil sales. Net sales for the quarter ended March 31, 2026, came in at US$30.3 million, with strong February and March demand making up for a slow January. On the…
